Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 101
of 6Next
1:

Effect of pathologic fractures on survival in multiple myeloma patients: a case control study.

Sonmez M, Akagun T, Topbas M, Cobanoglu U, Sonmez B, Yilmaz M, Ovali E, Omay SB.

J Exp Clin Cancer Res. 2008 Jun 10;27:11.

PMID: 18577267 [PubMed - indexed for MEDLINE]

2:

Pathologic fractures correlate with reduced survival in patients with malignant bone disease.

Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R.

Cancer. 2007 Oct 15;110(8):1860-7.

PMID: 17763372 [PubMed - indexed for MEDLINE]

3:

Surgical treatment for pathologic fracture.

Wedin R.

Acta Orthop Scand Suppl. 2001 Jun;72(302):2p., 1-29.

PMID: 11582636 [PubMed - indexed for MEDLINE]

4:

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs M, Blacklock H, Bell R, Simeone JF, Reitsma DJ, Heffernan M, Seaman J, Knight RD.

J Clin Oncol. 1998 Feb;16(2):593-602.

PMID: 9469347 [PubMed - indexed for MEDLINE]

5:

[Pathologic fractures: diagnostic and therapeutic considerations and results of treatment]

Maurer F, Ambacher T, Volkmann R, Weller S.

Langenbecks Arch Chir. 1995;380(4):207-17. German.

PMID: 7674795 [PubMed - indexed for MEDLINE]

6:

Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow.

Lecouvet FE, Malghem J, Michaux L, Michaux JL, Lehmann F, Maldague BE, Jamart J, Ferrant A, Vande Berg BC.

Radiology. 1997 Jul;204(1):201-5.

PMID: 9205247 [PubMed - indexed for MEDLINE]

7:

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT).

Björkstrand B, Svensson H, Goldschmidt H, Ljungman P, Apperley J, Mandelli F, Marcus R, Boogaerts M, Alegre A, Remes K, Cornelissen JJ, Bladé J, Lenhoff S, Iriondo A, Carlson K, Volin L, Littlewood T, Goldstone AH, San Miguel J, Schattenberg A, Gahrton G.

Bone Marrow Transplant. 2001 Mar;27(5):511-5.

PMID: 11313685 [PubMed - indexed for MEDLINE]

8:

Bisphosphonates in multiple myeloma.

Djulbegovic B, Wheatley K, Ross J, Clark O, Bos G, Goldschmidt H, Cremer F, Alsina M, Glasmacher A.

Cochrane Database Syst Rev. 2002;(3):CD003188. Review.

PMID: 12137679 [PubMed - indexed for MEDLINE]

9:

Bisphosphonates in multiple myeloma.

Djulbegovic B, Wheatley K, Ross J, Clark O, Bos G, Goldschmidt H, Cremer F, Alsina M, Glasmacher A.

Cochrane Database Syst Rev. 2001;(4):CD003188. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD003188.

PMID: 11687178 [PubMed - indexed for MEDLINE]

10:

[Bone lesions in elderly multiple myeloma]

Umeda M, Adachi Y, Tomiyama J, Takasaki M, Shin K, Mori M, Tsutsumi H, Murai Y, Mutoh Y, Tomoyasu S, Kawato M, Nakamura N, Metori S, Yamaguchi H; Society for Geriatric Hematology.

Nippon Ronen Igakkai Zasshi. 2002 Nov;39(6):631-8. Japanese.

PMID: 12518415 [PubMed - indexed for MEDLINE]

11:

The treatment of pathologic and impending pathologic fractures of the proximal femur in the elderly.

Behr JT, Dobozi WR, Badrinath K.

Clin Orthop Relat Res. 1985 Sep;(198):173-8.

PMID: 2411457 [PubMed - indexed for MEDLINE]

12:

Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.

Menssen HD, Sakalová A, Fontana A, Herrmann Z, Boewer C, Facon T, Lichinitser MR, Singer CR, Euller-Ziegler L, Wetterwald M, Fiere D, Hrubisko M, Thiel E, Delmas PD.

J Clin Oncol. 2002 May 1;20(9):2353-9.

PMID: 11981007 [PubMed - indexed for MEDLINE]

13:

Fracture risk with multiple myeloma: a population-based study.

Melton LJ 3rd, Kyle RA, Achenbach SJ, Oberg AL, Rajkumar SV.

J Bone Miner Res. 2005 Mar;20(3):487-93. Epub 2004 Nov 29.

PMID: 15746994 [PubMed - indexed for MEDLINE]

14:

Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma.

McCloskey EV, Dunn JA, Kanis JA, MacLennan IC, Drayson MT.

Br J Haematol. 2001 Jun;113(4):1035-43.

PMID: 11442499 [PubMed - indexed for MEDLINE]

15:

Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma.

Papagelopoulos PJ, Galanis EC, Greipp PR, Sim FH.

Clin Orthop Relat Res. 1997 Aug;(341):192-205.

PMID: 9269174 [PubMed - indexed for MEDLINE]

16:

Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.

Witzig TE, Gertz MA, Lust JA, Kyle RA, O'Fallon WM, Greipp PR.

Blood. 1996 Sep 1;88(5):1780-7.

PMID: 8781435 [PubMed - indexed for MEDLINE]

17:

A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis.

Gandhi M, Jestice H, Scott M, Bloxham D, Bass G, Craig J, Marcus R.

Bone Marrow Transplant. 1999 Aug;24(4):369-75.

PMID: 10467325 [PubMed - indexed for MEDLINE]

18:

Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. The results of the first 12 months of pamidronate therapy.

Kraj M, Pogłód R, Pawlikowski J, Maj S, Nasiłowska B.

Acta Pol Pharm. 2000 Nov;57 Suppl:113-6.

PMID: 11293237 [PubMed - indexed for MEDLINE]

19:

Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.

Mileshkin L, Honemann D, Gambell P, Trivett M, Hayakawa Y, Smyth M, Beshay V, Ritchie D, Simmons P, Milner AD, Zeldis JB, Prince HM.

Haematologica. 2007 Aug;92(8):1075-82. Epub 2007 Jul 20.

PMID: 17640854 [PubMed - indexed for MEDLINE]

20:

Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.

Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffernan M, Seaman J, Knight RD.

N Engl J Med. 1996 Feb 22;334(8):488-93.

PMID: 8559201 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 101
of 6Next